Term
|
Definition
9 -> (7+TF) -> 9a X -> (9a) -> Xa proThrombin -> (Xa) -> Thrombin Fibrinogen -> (thrombin) -> Fibrin clot
*fibrin binds platelets and crosslinks them *cascade is catalytic/amplifiable, NOT stoicheometric (1:1) *normal aPTT time = 30 sec |
|
|
Term
|
Definition
decreased cAMP thrombin ADP TXA2 5HT/serotonin |
|
|
Term
|
Definition
|
|
Term
Half-lives of clotting factors |
|
Definition
Factor VII 5 hours Protein C 6 hours Factor IX 15 hours Factor X 1 day Prothrombin 2-3 days |
|
|
Term
|
Definition
class - antithrombin MOA - huge sugar chain that inhibits thrombin by binding it to antithrombin. also binds factor Xa to antithrombin. it is catalytic bc once it facilitates binding it releases itself and can act again (so it's action is antithrombin dependent). Increases: LPL (which cleaves TGs) Decreases: thrombin, fibrin AE - thrombocytopenia, thrombosis |
|
|
Term
|
Definition
class - factor Xa inhibitor (LMWH) MOA - smaller sugar chain that inhibits factor Xa by binding it to antithrombin. it is also catalytic and antithrombin dependent. Decreases: factor Xa, thrombin, fibrin AE - thrombocytopenia, thrombosis |
|
|
Term
|
Definition
class - vitamin K reductase inhibitor MOA - keeps vitamin K in an oxidized state so it can't catalyze the carboxylation of clotting factors which lowers their affinity to Ca+ Decreases: various clotting factors AE - bleeding, necrosis, pregnancy-X |
|
|
Term
|
Definition
class - adenosine receptor inhibitor MOA - prodrug that prevents ADP from binding to platelets which in turn increases cAMP where: platelets Increases: cAMP Decreases: ADP AE - thrombocytopenia |
|
|
Term
|
Definition
class - PDE(3) inhibitor MOA - inhibits PDE(3) which converts cAMP where: platelets Increases: cAMP AE - headache |
|
|
Term
|
Definition
class - integrin inhibitor MOA - blocks integrin which is a receptor for fibrinogren on platelets where: platelets Decreases: binding/crosslinking AE - hypersensitivity (mouse part) |
|
|